Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6219581 | 0.88 | MAPT (0.36) | MAPTEPHX1 | |
| SCHEMBL5585363 | 0.85 | MAPT (0.37) | MAPTEGLN1POLBAPEX1TDP1 | |
| SCHEMBL22390581 | 0.85 | MAPT (0.37) | MAPTEGLN1POLBAPEX1TDP1 | |
| SCHEMBL27341 | 0.85 | MAPT (0.37) | MAPTEGLN1POLBAPEX1TDP1 | |
| SCHEMBL27596921 | 0.84 | MAPT (0.34) | MAPTPOLBAPEX1TDP1 | |
| Hydrochloric Acid SCHEMBL3839089 | 0.83 | MAPT (0.36) | MAPTEGLN1POLBAPEX1TDP1 | |
| SCHEMBL16207394 | 0.83 | MAPT (0.36) | MAPTEGLN1POLBAPEX1TDP1 | |
| Bromide SCHEMBL7615302 | 0.83 | MAPT (0.36) | MAPTEGLN1POLBAPEX1TDP1 | |
| Hydrochloric Acid SCHEMBL10904239 | 0.83 | MAPT (0.36) | MAPTEGLN1POLBAPEX1TDP1 | |
| Bromide SCHEMBL8064378 | 0.83 | MAPT (0.36) | MAPTEGLN1POLBAPEX1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1987007602-A2 | N-(5-SUBSTITUTED METHYLENE) PHENYL HERBICIDES | RHONE-POULENC AGROCHIMIE (FR) | 1987-12-17 | — | — | WO | claimed |
| JP-5155836-A | — | — | None | — | — | JP | disclosed |
| US-20250136542-A1 | CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNODULATORY AND ANTI-PROLIFERATIVE AGENTS | IMMUNIC AG (DE) | 2025-05-01 | — | — | US | disclosed |
| EP-4438591-A1 | NOVEL CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | Immunic AG (DE) | 2024-10-02 | — | — | EP | disclosed |
| US-12037305-B2 | Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents | IMMUNIC AG (DE) | 2024-07-16 | — | — | US | disclosed |
| EP-3765439-B1 | NOVEL CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | IMMUNIC AG (DE) | 2024-05-01 | — | — | EP | disclosed |
| US-11186793-B2 | Protection of liquid fuels | PALOX LIMITED (CY) | 2021-11-30 | — | — | US | disclosed |
| US-20210017125-A1 | Novel calcium salt polymorphs as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents | IMMUNIC AG (DE) | 2021-01-21 | — | — | US | disclosed |
| EP-3765439-A1 | NOVEL CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | Immunic AG (DE) | 2021-01-20 | — | — | EP | disclosed |
| WO-2019175396-A1 | NOVEL CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | IMMUNIC AG (DE) | 2019-09-19 | — | — | WO | disclosed |
| WO-1993022280-A1 | SUBSTITUTED CYCLOHEXENE-1,2-BICARBOXYLIC ACID DERIVATIVES AND RAW MATERIALS FOR PRODUCING THEM | BASF AKTIENGESELLSCHAFT (DE) | 1993-11-11 | — | — | WO | disclosed |
| JP-H05155836-A | N-PHENYLTETRAHYDROPHTHALAMIC ACID DERIVATIVE AND HERBICIDE CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT | CENTRAL GLASS CO LTD | 1993-06-22 | — | — | JP | disclosed |
| EP-0496900-A1 | N-ACYL-N-PHENYLTETRAHYDROPHTHALAMIC ACID DERIVATIVE, PRODUCTION THEREOF, AND HERBICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | CENTRAL GLASS COMPANY, LIMITED (JP) | 1992-08-05 | — | — | EP | disclosed |
| WO-1987007602-A2 | N-(5-SUBSTITUTED METHYLENE) PHENYL HERBICIDES | RHONE-POULENC AGROCHIMIE (FR) | 1987-12-17 | — | — | WO | disclosed |
| EP-0073409-B1 | N-SUBSTITUTED-TETRAHYDROISOPHTHALIMIDE DERIVATIVES | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1986-05-07 | — | — | EP | disclosed |
| EP-0031924-B1 | USE OF ALCANOL-AMINE SALTS OF CYCLIC AMIDOCARBOXYLIC ACIDS AS CORROSION INHIBITORS IN AQUEOUS SYSTEMS | BASF Aktiengesellschaft (DE) | 1983-05-18 | — | — | EP | disclosed |
| EP-0073409-A1 | N-substituted-tetrahydroisophthalimide derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1983-03-09 | — | — | EP | disclosed |
| US-4362546-A | Tetrahydrophthalamide derivatives, herbicidal compositions and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-12-07 | — | — | US | disclosed |
| US-4328367-A | HERBICIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-05-04 | — | — | US | disclosed |
| EP-0031924-A1 | Use of alcanol-amine salts of cyclic amidocarboxylic acids as corrosion inhibitors in aqueous systems | BASF Aktiengesellschaft (DE) | 1981-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037305-B2 | Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents | DHODH, CA2, FH | MAPT 411/4885EPHX1 718/4885EGLN1 2849/4885 |
| US-20210017125-A1 | Novel calcium salt polymorphs as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents | DHODH, FH, HADHB | MAPT 823/4885EPHX1 1153/4885EGLN1 3277/4885 |
| US-20250136542-A1 | CALCIUM SALT POLYMORPHS AS ANTI-INFLAMMATORY, IMMUNODULATORY AND ANTI-PROLIFERATIVE AGENTS | DHODH, CA2, DPYD | MAPT 305/4885EPHX1 737/4885EGLN1 2750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.